G

GentiBio

91 employees

GentiBio is a biotherapeutics company developing engineered regulatory T cells programmed to treat autoimmune allergic diseases.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Life Science

Date founded

2020

Funding rounds raised

Total raised

$157M

from 7 investors over 7 rounds

G

GentiBio raised $157M on August 11, 2021

Investors: Seattle Children's, RA Capital Management, L.P., JDRF T1D Fund, OrbiMed Advisors and Avidity Partners

G

GentiBio raised $20M on August 5, 2020

Investors: OrbiMed Advisors and RA Capital Management, L.P.

FAQ